Product NDC: | 63323-294 |
Proprietary Name: | Polocaine-MPF |
Non Proprietary Name: | MEPIVACAINE HYDROCHLORIDE |
Active Ingredient(s): | 20 mg/mL & nbsp; MEPIVACAINE HYDROCHLORIDE |
Administration Route(s): | EPIDURAL; INFILTRATION |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63323-294 |
Labeler Name: | APP Pharmaceuticals, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA089409 |
Marketing Category: | ANDA |
Start Marketing Date: | 20090721 |
Package NDC: | 63323-294-20 |
Package Description: | 1 VIAL in 1 BOX (63323-294-20) > 20 mL in 1 VIAL |
NDC Code | 63323-294-20 |
Proprietary Name | Polocaine-MPF |
Package Description | 1 VIAL in 1 BOX (63323-294-20) > 20 mL in 1 VIAL |
Product NDC | 63323-294 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | MEPIVACAINE HYDROCHLORIDE |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | EPIDURAL; INFILTRATION |
Start Marketing Date | 20090721 |
Marketing Category Name | ANDA |
Labeler Name | APP Pharmaceuticals, LLC |
Substance Name | MEPIVACAINE HYDROCHLORIDE |
Strength Number | 20 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Local Anesthesia [PE] |